These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2463265

  • 1. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T, Saura R, Hirohata K, Ziff M.
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [Abstract] [Full Text] [Related]

  • 2. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
    Gupte A, Mumper RJ.
    Free Radic Biol Med; 2007 Nov 01; 43(9):1271-8. PubMed ID: 17893040
    [Abstract] [Full Text] [Related]

  • 3. Bucillamine inhibits T cell adhesion to human endothelial cells.
    Eguchi K, Kawakami A, Ida H, Nakashima M, Yamashita I, Sakai M, Shimada H, Terada K, Fukuda T, Ishimaru T.
    J Rheumatol; 1992 Jul 01; 19(7):1045-50. PubMed ID: 1512757
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE.
    J Clin Invest; 1984 Jan 01; 73(1):53-65. PubMed ID: 6606652
    [Abstract] [Full Text] [Related]

  • 5. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE, Ziff M.
    J Immunol; 1978 Mar 01; 120(3):1006-13. PubMed ID: 632576
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human endothelial cell proliferation by gold compounds.
    Matsubara T, Ziff M.
    J Clin Invest; 1987 May 01; 79(5):1440-6. PubMed ID: 3106416
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE, Ziff M.
    J Clin Invest; 1980 May 01; 65(5):1069-76. PubMed ID: 6965944
    [Abstract] [Full Text] [Related]

  • 8. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro.
    Matsubara T, Hirohata K.
    Arthritis Rheum; 1988 Aug 01; 31(8):964-72. PubMed ID: 3261590
    [Abstract] [Full Text] [Related]

  • 9. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A, Mumper RJ.
    J Inorg Biochem; 2007 Apr 01; 101(4):594-602. PubMed ID: 17275091
    [Abstract] [Full Text] [Related]

  • 10. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE.
    Z Rheumatol; 1988 Apr 01; 47 Suppl 1():6-8. PubMed ID: 2975107
    [Abstract] [Full Text] [Related]

  • 11. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G, Root RK.
    J Immunol; 1985 May 01; 134(5):3371-8. PubMed ID: 2984288
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo interactions of D-penicillamine with tumors.
    Samoszuk M, Nguyen V.
    Anticancer Res; 1996 May 01; 16(3A):1219-23. PubMed ID: 8702240
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H, Sato H, Kamimura T, Hirata D, Iwamoto M, Yoshio T, Mimori A, Masuyama JI, Kano S, Minota S.
    J Rheumatol; 2000 Jun 01; 27(6):1358-64. PubMed ID: 10852254
    [Abstract] [Full Text] [Related]

  • 19. A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization.
    Yoshikawa A, Saura R, Matsubara T, Mizuno K.
    Kobe J Med Sci; 1997 Aug 01; 43(3-4):109-20. PubMed ID: 9489296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.